What Makes Biogen and Bristol-Myers Squibb Such Attractive Takeover Targets

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-stock-positive.jpg" NAME"What Makes Biogen and Bristol-Myers Squibb Such Attractive Takeover Targets" ALT"What Makes Biogen and Bristol-Myers Squibb Such Attractive Takeover Targets"June 27, 2017By Mark Terry, BioSpace.com... Source: BioSpace

Continue ReadingWhat Makes Biogen and Bristol-Myers Squibb Such Attractive Takeover Targets

Merck & Co.'s Midas Touch Continues as Heart Drug Succeeds Where Pfizer, Eli Lilly and Roche's Failed

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-merck.jpg" NAME"Merck's Midas Touch Continues as Heart Drug Succeeds Where Pfizer, Lilly and Roche's Failed" ALT"Merck's Midas Touch Continues as Heart Drug Succeeds Where Pfizer, Lilly and Roche's Failed"June…

Continue ReadingMerck & Co.'s Midas Touch Continues as Heart Drug Succeeds Where Pfizer, Eli Lilly and Roche's Failed